Search Results 991-1000 of 19441 for B cell lymphomas

  1. Models for Cell Targeting - Virology, Vector and Vaccine Engineering: Michael A. Barry - Mayo Clinic Research

    B cell cancer, Chronic lymphocytic leukemia (CLL). Need for systemic distribution, but cancer-targeted delivery; Absence of cell-specific ligands; Ideal ...

  2. FLIPI24 Model - Lymphoma Biostatistics and Data Science: Matthew J. Maurer - Mayo Clinic Research

    FLIPI24 is prognostic model and clinical trial enrichment tool developed by Mayo Clinic to calculate treatment consideration for patients with newly ...

  3. Daratumumab for Chemotherapy-Refractory Minimal Residual Disease in T Cell ALL - Mayo Clinic

    ... B-cell ... Most subtypes of acute myeloid leukemia (AML) and acute lymphoblastic leukemia/lymphoma ... B-cell ALL/L had more favorable survival than T ...

  4. Doctors and departments - Mayo Clinic

    Research. Mayo Clinic doctors and researchers are studying lymphoma to look for new ways to improve diagnosis and treatment for this cancer. Cancer research is ...

  5. Doctors and departments - Mayo Clinic

    Hodgkin lymphoma (Hodgkin disease). Departments and specialties. Mayo Clinic has one of the largest and most experienced practices in the United States, with ...

  6. A Study of Interstitial Lung Disease Relating to the Development of Fibrosis in the Lungs - Mayo Clinic

    Fibroblasts are cells that are responsible for the formation of scarring in the lungs. Specific markers found in the surface of B lymphocytes will also be ...

  7. Advancing understanding of CAR-T cell therapy for cancer - Mayo Clinic News Network

    As a treatment that can be individualized for patients, CAR-T cell therapy currently is being used primarily for blood cancers like leukemias and lymphomas.

  8. Publications - Eric C. Ehman, M.D. - Mayo Clinic

    Publications. Print. Chen PH, Desjardins B, Strassner B, Forghani R, Bodak R ... B-cell lymphoma. Medicine (Baltimore). 2023 Feb 10; 102 (6):e32665. View ...

  9. ABT-888 With Cyclophosphamide in Refractory BRCA-Positive Ovarian, Primary Peritoneal or Ovarian High-Grade Serous Carcinoma, Fallopian Tube Cancer, Triple-Negative Breast Cancer, and Low-Grade Non-Hodgkin's Lymphoma - Mayo Clinic

    ... lymphoma, follicular or diffuse—recurrent/refractory, Marginal zone B-cell lymphoma: splenic, nodal, extranodal (this includes MALT)—recurrent/refractory ...

  10. Building a Healthy Body after Cancer: Challenges and Opportunities in Healthy Exercise after Treatment for Young Adult Lymphoma Survivors - Mayo Clinic

    mayo-mobile-logo-image. Menu; Search. Search. All ... lymphoma survivors. In addition, we will look to ... lymphoma survivors. Participation eligibility.